Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Editorial (Hot Topic: Mitochondrion: An Organelle More and More Implication in New Processes)
Volume: 7 Issue: 2
Author(s): Ana Coto-Montes
Affiliation:
Export Options
About this article
Cite this article as:
Coto-Montes Ana, Editorial (Hot Topic: Mitochondrion: An Organelle More and More Implication in New Processes), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2013; 7 (2) . https://dx.doi.org/10.2174/1872214811307020001
DOI https://dx.doi.org/10.2174/1872214811307020001 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
16
Related Articles
-
Synthesis of 1<i>H</i>-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Agents
Anti-Cancer Agents in Medicinal Chemistry Editorial Nutritional Therapy in Metabolic Syndrome
Current Vascular Pharmacology NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets On the Use of Hydrogels in Cell Encapsulation and Tissue Engineering Systems
Recent Patents on Drug Delivery & Formulation Human Exposure to Endocrine Disruptors and Breast Milk
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Growth Factors in Arthritis: A Rational for Restoring the IGF-I Response in Chondrocytes
Current Rheumatology Reviews Apoptosis in Sepsis: Mechanisms, Clinical Impact and Potential Therapeutic Targets
Current Pharmaceutical Design Discovery of Novel NAMPT Inhibitors Based on Pharmacophore Modeling and Virtual Screening Techniques
Combinatorial Chemistry & High Throughput Screening An Evidence-Based Systematic Review of Stevia by the Natural Standard Research Collaboration
Cardiovascular & Hematological Agents in Medicinal Chemistry The Use of Chronobiotics in the Resynchronization of the Sleep/Wake Cycle. Therapeutical Application in the Early Phases of Alzheimer's Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Role of Polymorphisms in Factor V (FV Leiden), Prothrombin, Plasminogen Activator Inhibitor Type-1 (PAI-1), Methylenetetrahydrofolate Reductase (MTHFR) and Cystathionine β-Synthase (CBS) Genes as Risk Factors for Thrombophilias
Mini-Reviews in Medicinal Chemistry Identification of Novel Breast Cancer Genes based on Gene Expression Profiles and PPI Data
Current Proteomics Redifferentiation Therapy in Advanced Thyroid Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Recent Techniques Used in Reproductive Medicine: Outcomes for Gametes Manipulation
Current Women`s Health Reviews Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Modulating Fatty Acid Metabolism and the AMP-Activated Protein Kinase Pathway as a Target for Obesity Therapy
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Modelling of Human Leucyl Aminopeptidases for in silico Off Target Binding Analysis of Potential Plasmodium falciparum Leucine Aminopeptidase (PfA-M17) Specific Inhibitors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) VEGF Signal System: The Application of Antiangiogenesis
Current Medicinal Chemistry Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease
Current Medicinal Chemistry Patent Selections
Recent Patents on Regenerative Medicine